Deal Watch: Genentech Inks New Collaborations With Skyhawk, Convelo

 
• By Joseph Haas, Ian Haydock, and Alexandra Shimmings

Skyhawk continues its recent spate of deal-making, using its SkyStar platform in a deal with Genentech, which also is looking into neurology with Convelo. AbbVie buys STING specialist Mavupharma, while Recordati pays Novartis $390m for Cushing’s products.

DealWatch_1200x675
Mirati Teams Up With Novartis For KRAS G12C Inhibitor Combo

More from Deals

More from Business